Shenzhen YHLO Biotech Co., Ltd. Share Price
Equities
688575
CNE100005204
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14.11 CNY | -0.98% |
|
-3.49% | -10.70% |
| 11-28 | YHLO Biotech Gets Dutch Certification for HIV Kit | MT |
| 11-26 | YHLO Biotech Gets Guangdong Registrations for sST2 Test Kit, Microfluidic Analyzer | MT |
| Capitalization | 8.05B 1.14B 970M 906M 850M 1.57B 103B 1.71B 10.55B 4.1B 48.59B 4.28B 4.19B 177B | P/E ratio 2025 * |
22.6x | P/E ratio 2026 * | 17.8x |
|---|---|---|---|---|---|
| Enterprise value | 8.05B 1.14B 970M 906M 850M 1.57B 103B 1.71B 10.55B 4.1B 48.59B 4.28B 4.19B 177B | EV / Sales 2025 * |
3.79x | EV / Sales 2026 * | 3.14x |
| Free-Float |
42.44% | Yield 2025 * |
0.71% | Yield 2026 * | 2.13% |
| 1 day | -0.98% | ||
| 1 week | -3.49% | ||
| Current month | -4.21% | ||
| 1 month | -7.17% | ||
| 3 months | -6.86% | ||
| 6 months | -6.18% | ||
| Current year | -10.70% |
| 1 week | 14.03 |  | 14.56 |
| 1 month | 14.03 | | 16.88 |
| Current year | 13.95 | | 18.1 |
| 1 year | 13.95 | | 18.1 |
| 3 years | 13.95 | | 28.6 |
| 5 years | 13.95 | | 52.71 |
| 10 years | 13.95 | | 52.71 |
| Manager | Title | Age | Since |
|---|---|---|---|
Yong Bo Song
CEO | Chief Executive Officer | 41 | 30/11/2012 |
Li Sheng Liao
DFI | Director of Finance/CFO | 46 | 21/12/2022 |
Chun Gen Qian
CTO | Chief Tech/Sci/R&D Officer | 43 | 30/09/2015 |
| Director | Title | Age | Since |
|---|---|---|---|
Kun Hui Hu
CHM | Chairman | 34 | 31/12/2017 |
Yong Bo Song
CHM | Chairman | 41 | 30/11/2012 |
Deng Ming Liu
BRD | Director/Board Member | 50 | 27/06/2019 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.98% | -3.49% | -20.06% | -49.52% | 1.15B | |
| -0.01% | +0.01% | +0.01% | +45.52% | 12.57B | |
| +2.75% | +5.66% | +22.76% | +44.59% | 11.87B | |
| +1.08% | +2.31% | -19.11% | +2.01% | 7.51B | |
| +1.31% | -0.43% | +20.82% | -13.37% | 6.04B | |
| -2.84% | -0.22% | +14.17% | +16.64% | 5.22B | |
| -1.49% | -2.44% | +0.77% | -3.41% | 5.04B | |
| -3.20% | -3.67% | -7.95% | +68.72% | 4.8B | |
| +0.05% | -.--% | +45.27% | +16.90% | 4.7B | |
| +0.42% | -4.17% | +43.75% | -13.54% | 1.96B | |
| Average | -0.29% | -0.51% | +10.04% | +11.45% | 6.09B | |
| Weighted average by Cap. | +0.18% | +0.70% | +9.33% | +23.51% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 2.12B 301M 256M 239M 224M 414M 27.12B 451M 2.78B 1.08B 12.81B 1.13B 1.1B 46.69B | 2.56B 363M 309M 288M 270M 500M 32.72B 544M 3.36B 1.3B 15.46B 1.36B 1.33B 56.32B |
| Net income | 329M 46.6M 39.64M 37.01M 34.73M 64.21M 4.2B 69.9M 431M 168M 1.99B 175M 171M 7.23B | 452M 64.02M 54.47M 50.85M 47.71M 88.22M 5.77B 96.05M 592M 230M 2.73B 240M 235M 9.94B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/12/25 | 14.11 ¥ | -0.98% | 5,415,553 |
| 10/12/25 | 14.25 ¥ | 0.00% | 3,905,996 |
| 09/12/25 | 14.25 ¥ | -0.90% | 3,390,769 |
| 08/12/25 | 14.38 ¥ | -0.62% | 4,410,338 |
| 05/12/25 | 14.47 ¥ | +0.49% | 2,922,396 |
End-of-day quote Shanghai S.E., December 10, 2025
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Annual profits - Rate of surprise
- Stock Market
- Equities
- 688575 Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition